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An increasing number of plasma membrane proteins have been
shown to be attached to the membrane via a glycosyl-
phosphatidylinositol (GPI) moiety. All eukaryotes share a highly
conserved GPI-core structure EthN-P-Man
$
-GlcN-PI, where
EthN is ethanolamine. We have identified a protein encoded by
the yeast open reading frame YGL142C that shares 33% identity
with the human Pig-B protein. Deletion of this essential gene
leads to a block in GPI anchor biosynthesis. We therefore named
INTRODUCTION
Glycosylphosphatidylinositol (GPI) anchoring represents a
mechanism for attachment of proteins to membranes found in all
eukaryotic cells [1,2]. All eukaryotes share the common GPI core
structure EthN-P-6Mana-1,2Mana-1,6Mana1,4-GlcNa-1,6-
myo-inositol-P-lipid, where EthN is ethanolamine. Modifications
of this core structure can occur on different mannose residues
and depends on the species as well as on its developmental stage.
The lipid moiety of the GPI anchor is also subject to modi-
fications, such as variations of the fatty acids, ceramide
remodelling or the attachment of alkyl chains [1].
The complete GPI precursor, whose structure has been solved
for some species, is assumed to be assembled by sequential
addition of the sugar components and ethanolamine to
phosphatidylinositol [3]. The complete precursor is transferred
en bloc to the anchor-attachment site of the protein (x-site) with
concomitant release of a C-terminal peptide [4]. Anchor at-
tachment is thought to occur as a transamidation reaction [5,6].
A protein to be GPI-anchored carries two signal sequences : a
cleavable N-terminal signal sequence that causes the protein to
be translocated into the lumen of the endoplasmic reticulum
(ER), and a C-terminal signal sequence that directs attachment
of the GPI anchor. The consensus sequence for GPI-anchor
addition consists of an amino acid with a small side-chain at the
x-site, two amino acids with small side-chains in positions x­1
and x­2, and a short hydrophilic spacer region followed by a
hydrophobic domain of about 15–20 amino acids [7].
The identification of at least eight complementation classes of
mutants from murine lymphoma and human K562 cells, lacking
the expression of GPI-anchored proteins at the cell surface, led
to the characterization of genes involved in mammalian anchor
biosynthesis [3]. Three complementation classes, A, C and H, are
blocked in the first step of precursor synthesis, which is the ad-
dition of GlcNAc to PI [8]. Class J mutants and class L mutants
are defective in deacetylating GlcNAc-PI to give GlcN-PI [9–11].
Class E mutants are defective in dolichyl (Dol)-P-Man synthase,
Abbreviations used: ER, endoplasmic reticulum; EthN, ethanolamine; GPI, glycosylphosphatidylinositol ; GU, glucose unit.
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the gene GPI10. Gpi10p and Pig-B are functional homologues
and the lethal deletion of GPI10 can be rescued by expression of
the PIG-B cDNA. As found for PIG-B mutant cells, gpi10
deletant cells cannot attach the third mannose in an a-1,2 linkage
to the GPI core-structure intermediate. Overexpression of GPI10
gives partial resistance to the GPI-synthesis inhibitor YW3548,
suggesting that this gene product may affect the target of the
inhibitor.
thereby affecting GPI mannosylation and N-linked glycosylation
[12]. Class B mutant cells are blocked in the addition of the third
mannose to the intermediate structure [13], the class F mutation
affects the transfer of the terminal ethanolamine to the third
mannose [12], and class K mutants accumulate the complete
precursor without transferring it to the protein [10]. Whereas in
mammalian cells, several cDNAs that encode components of the
GPI synthesis machinery (PIG-A, PIG-H, PIG-L, PIG-F, PIG-C
and PIG-B) have been cloned [11,13–17], only genes involved in
the first step of anchor synthesis (GPI1, GPI2, GPI3}SPT13) and
in anchor attachment (GAA1, GPI8) have been identified from
yeast [18–21]. Yeast mutants that affect various steps of GPI-
anchor synthesis have also been described [22].
The core structure of the GPI anchor contains three mannose
residues which are all assumed to be transferred from Dol-P-
Man as donor [23]. The mannose residues were found to be
attached in different linkages, suggesting that at least three gene
products are involved in GPI mannosylation. The Pig-B protein
is required for the transfer of the third mannose in an a-1,2
linkage to the core structure, but to date, no enzymic activity of
the Pig-B protein has been shown [13]. A yeast mutant, blocking
a similar step as the Pig-B mutant, has been isolated [22].
Addition of the third mannose can also be blocked using a
species-specific inhibitor, YW3548 [24]. YW3548 blocks GPI-
anchor synthesis in mammalian cells and in yeast, but not in
protozoa.
In this study, we report the identification of a yeast gene,
GPI10, which appears to be the functional homologue of the
human PIG-B gene. In order to study the function of this
essential gene, we placed GPI10 under the control of the
GAL1}10 promoter. When GPI10 expression was turned off, we
found that inositol was no longer incorporated into proteins and
that the maturation of Gas1p, a major GPI-anchored protein
from yeast, was strongly reduced. Under these conditions, we
observed the accumulation of the GPI intermediate Man
#
-GlcN-
(acyl)PI, and of a novel yeast GPI-derived structure that was
sensitive to treatment with HF and to Jack bean mannosidase,
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most likely Man-(EthN-P)Man-GlcN-(acyl)PI. The appearance
of this novel lipid was blocked by addition of YW3548, a GPI-
synthesis inhibitor. Overexpression of GPI10 rendered wild-type
cells partially resistant to YW3548.
MATERIALS AND METHODS
Strains and growth conditions
Cells were grown to saturation in either YPG [3% (v}v) glycerol,
2% (w}v) peptone, 1% (w}v) yeast extract, 40 mg}l each of
adenine, uracil and tryptophan] or in SGYE [3% (v}v) glycerol,
0.67% (w}v) yeast nitrogen base, 0.2% (w}v) yeast extract and
the required nutrients] and used to inoculate the glucose-
containing media SDYE [0±2% (w}v) yeast extract, 0±67%
(w}v) yeast nitrogen base and 5% (w}v) glucose] or YPUAD
[1±0% (w}v) yeast extract, 2% (w}v) peptone, 5% (w}v) glucose
and 40 mg}l each of uracil and adenine]. For overexpression
experiments, cells were grown in YGal medium [2% (w}v)
galactose, 1% (w}v) yeast extract, 2% (w}v) peptone, 40 mg}l
of each of adenine, uracil and tryptophan]. Sporulation of yeast
strains was on minimal sporulation medium (1% potassium
acetate, 2% Bacto-agar, and the required nutrients to comp-
lement auxotrophies).
The full-length sequence of GPI10 was replaced by the KanMX
module using a PCR-based strategy [25]. A knockout cassette
was constructed using a short flanking homology strategy and
the oligomers : (upstream) 5« TCTCTCAACGATAGGGTCT-
GATTTATTAATTTTACTACTGCCGAAACGTACGCTGC-
AGGTCGACC 3« and (downstream) 5« ATCGATGAATT-
CGAGCTCGTTATGGTAAGTTAATATCGCTATAAGGT-
CGCCGTCTATAAATTTAAA 3«.
This cassette was transformed into the diploid strains FY1679
and CEN.PK2. Deletion of the gene was monitored by resistance
to geneticin (Gibco-BRL) and resistant colonies were confirmed
by PCR analysis. For overexpression studies from the GAL1
promoter, RH1657 was used. For galactose-depletion studies,
RH3699 was transformed with pGal-GPI10 and tetrads were
dissected, generating spore A (RH3994), spore B (RH3995),
spore C (RH3996) and spore D (RH3997). For in io mannose
labelling experiments, RH3998 and RH3999 were used. All yeast
strains used in this study are shown in Table 1.
Plasmids
pGal-GPI10 was constructed by PCR amplification of the full-
length GPI10 coding sequence from genomic DNA, with the
primers (upstream) 5« GATAGTCTAGAATTGTGTAATC
CAA 3« and (downstream) 5« GTAAACTGATAAGTGAAG-
CATGCAC 3«, using PFU Polymerase (Stratagene). The PCR
Table 1 Strains of Saccharomyces cerevisiae that were used for this study
Strain Phenotype Source
FY1679 Mata/a ura3-52/ura3-52 leu2D/­trp1D63/­his3D200/­ Eurofan
Cen.PK2 Mata/a ura3-52/ura3-52 leu2-3,112/leu2-3,112 trp1-289/trp1-289 his3D1/his3D1 Eurofan
RH3698 FY1679, but gpi10D : : KanMX/GPI10 This study
RH3699 Cen.PK2, but gpi10D : : KanMX/GPI10 This study
RH3994 Mata ura3-52 leu2-3,112 trp1-289 his3D pGal-GPI10 This study
RH3995 Mata gpi10D : : KanMX ura3-52 leu2-3,112 trp1-289 his3D pGal-GPI10 This study
RH3996 Mata ura3-52 leu2-3,112 trp1-289 his3D pGal-GPI10 This study
RH3997 Mata gpi10D : : KanMX ura3-52 leu2-3,112 trp1-289 his3D pGal-GPI10 This study
RH3998 Mata pmi40 ura3 leu2 ade2 trp1 his4 pGal-GPI10 This study
RH3999 Mata pmi40 gpi10D : : KanMX ura3 leu2 ade2 trp1 his4 pGal-GPI10 This study
RH1657 Mata his4 leu2 ura3 lys2 bar1 Laboratory strain
fragment containing sites for XbaI (upstream oligomer) and SphI
(downstream oligomer) was subcloned into the XbaI–SphI site of
the pSEYC68 vector containing the GAL1}10 promoter cloned
into the EcoRI–BamHI site (referred to as pGal).
p425-PIG-B was prepared by subcloning the full-length PIG-
B cDNA [13] into the EcoRV site of pBluescriptII (Stratagene),
and the fragment generated by cutting with SpeI and SalI was
ligated into p425 digested with SpeI and SalI.
[3H]myo-Inositol labelling of proteins
Wild-type cells or gpi10D : :KanMX cells carrying pGal-GPI10
were grown in SGYE to saturation and used to inoculate SDYE
(5% glucose) in which they were grown for about 16 h. Cells
(5¬10() were washed twice in SD-inositol medium (5% glucose)
[26], resuspended in 500 ll of SD without inositol (5% glucose)
and depleted of inositol for 10 min before the addition of 15 lCi
of [$H]myo-inositol (Dupont de Nemours, Bad Homburg, Ger-
many). Cells were labelled for 30 min. A total protein extract
was prepared by lysing the cells in TEPI [100 mM Tris}HCl,
pH 7.5}10 mM EDTA}proteinase inhibitors (1 lg}ml pepstatin,
1 lg}ml leupeptin, 1 lg}ml antipain)] by vortexing for 4¬1 min
with glass beads. Total protein was precipitated with trichloro-
acetic acid and the precipitates were washed with acetone
and resuspended in Laemmli protein sample buffer. The proteins
were separated by SDS}PAGE (10% acrylamide) and, after
incubation of the gel in 1 M sodium salicylate, the radioactivity
was detected by fluorography.
Pulse–chase analysis of Gas1p and CPY
Pulse–chase labelling and analysis of immunoprecipitates was
done as described previously [26]. Briefly, wild-type cells and
gpi10D : :KanMX cells carrying pGal-GPI10 were grown to
saturation in SGYE and shifted to SDYE (5% glucose) for 16 h.
Cells were harvested and washed with SD* [5% (w}v) glucose,
0.67% (w}v) yeast nitrogen base and the required nutrients].
Cells (2.5¬10( per time point) were resuspended in 1 ml of SD*,
preincubated for 10 min, labelled with TRANS $&S-label (Dupont
de Nemours) and chased for the indicated times with 0.003%
(w}v) methionine}0.003% (w}v) cysteine}3 mM (NH
%
)
#
SO
%
.
Aliquots were taken and the chase was stopped by adding NaN
$
and NaF to a final concentration of 10 mM. Cells were lysed
by vortexing for 4¬1 min with glass beads in TEPI. The lysates
were boiled in the presence of 1% SDS for 5 min and centrifuged
for 15 min in an Eppendorf centrifuge. The supernatant was
added to 5 ml of TNET (100 mM Tris}HCl, pH 8}100 mM
NaCl}5 mM EDTA}1% Triton X-100) and the extracts were
incubated with polyclonal antisera against Gas1p or CPY and
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Protein A–Sepharose (Pharmacia, Uppsala, Sweden) for 3 h at
room temperature. The immunoprecipitates were washed four
times with TNET, once with 20 mM Tris, pH 7.4, resuspended in
Laemmli sample buffer and analysed by SDS}PAGE, followed
by exposure and quantification of the gel on a PhosphorImager
(Molecular Dynamics, Sunnyvale, CA, U.S.A.). The percentage
of mature Gas1p was determined as the percentage of the total
Gas1p signal found in the 125 kDa form.
Glycolipid labelling in vivo
["%C]Mannose labelling experiments in io using RH3998 and
RH3999 were performed as described [27]. In brief, pmi40 or
pmi40 gpi10D : :KanMX cells carrying the plasmid pGal-GPI10
were grown for 16 h in SDCU medium [5% (w}v) glucose}1%
(w}v) peptone} 0.67% (w}v) yeast nitrogen base}0.1% (w}v)
mannose, supplemented with 40 mg}l uracil]. Cells (3¬10() were
resuspended in SPCU medium [0.1% (w}v) glucose, 2% (w}v)
pyruvate, 0.67% (w}v) yeast nitrogen base and the required
nutrients], preincubated at a non-permissive temperature for
pmi40 for 20 min and labelled with 25 lCi of ["%C]mannose for
45 min. In some experiments, cells were incubated with 5 lg}ml
YW3548 (Novartis AG, Basel, Switzerland) for 10 min before
addition of the radioactivity. The reaction was stopped by
the addition of 10 mM NaF}10 mM NaN
$
, and lipids were ex-
tractedwith CHCl
$
}CH
$
OH}H
#
O (10:10:3, by vol.). Lipids were
desalted by phase partitioning between n-butanol and 0.1 mM
EDTA}5 mM Tris}HCl, pH 7.5, and analysed by TLC using
CHCl
$
}CH
$
OH}H
#
O (10:10:3, by vol.) as solvent. For struc-
tural analysis, the accumulated lipids were extracted from the
TLC plate, converted into hydrophilic fragments or core glycans
and analysed by Bio-Gel P4 or high-pH anion-exchange
chromatography respectively, as described previously [28,29].
The hydrophilic fragment generated using HNO
#
was digested
with Jack bean mannosidase (Sigma) for 40 h with 2¬1.5 units.
The resulting fragment was desalted and purified on a G-15
column, then analysed on Dionex as above.
Halo assay
RH1657 cells expressing either pGal or pGal-GPI10 were grown
to saturation in YGal medium. Cells (5¬10') were included in
10 ml agar plates (0.8% agar) of the same media and 4 ll of
YW3548 at different concentrations was spotted on the plate.
RESULTS
Identification of GPI10
A database search using the National Center of Biotechnology
Information BLAST server indicated a large extent of homology
between the protein encoded by the yeast open reading frame
YL142C and the human Pig-B protein. Owing to the results
presented below, we named this gene GPI10. The GPI10 gene
encodes a protein of 616 amino acids with a predicted size of
about 72 kDa. It shows 33% identity with and 58% similarity to
the human PIG-B gene (Figure 1), the potential third mannosyl-
transferase producing the GPI anchor. In addition, the hydro-
phobicity profiles of the two proteins are very similar (results not
shown).
GPI10 is essential and its deletion can be rescued by expression
of the human PIG-B cDNA
To test whether GPI10 is an essential gene, we constructed a
KanMX knockout cassette and transformed it into the diploid
Figure 1 Sequence alignment of Gpi10p and the Pig-B protein
The sequence alignment was done using the BESTFIT program of the Wisconsin Package
Version 9.0, Genetics Computer Group (GCG), Madison, WI, U.S.A. Identical residues are shown
in boxes.
wild-type strain Cen.PK2 to disrupt the GPI10 gene [25]. Upon
tetrad dissection, we found that only two spores from each tetrad
could grow (Figure 2A). The growing spores were sensitive to
geneticin, showing that spores that were deleted for GPI10 were
inviable. GPI10 was also found to be essential in other strain
backgrounds (results not shown).
To study the function of the GPI10 gene product, we con-
structed a conditional mutant of GPI10 by cloning the gene
under control of the GAL1}10 promoter on a centromeric
plasmid. In this way, the expression of GPI10 can be turned off
simply by shifting the cells from glycerol-containing medium
(SGYE or YPG), in which the promoter is not repressed, to
glucose-containing medium (SDYE or YPD, both containing
5% glucose) where it is. The Gal construct of GPI10 (pGal-
GPI10) was functional and could restore growth of
gpi10D : :KanMX spores (Figure 2B). This construct was used to
perform Gpi10p depletion studies.
GPI10 had been identified based on its high degree of homology
to the human PIG-B gene. We therefore tested whether GPI10
could be functionally replaced by PIG-B. PIG-B was cloned into
a yeast multicopy vector (p425) behind the MET promoter,
which is activated in the absence of methionine. p425-PIG-B was
transformed into the Cen.PK2 diploid strain which is het-
erozygous for gpi10D : :KanMX. The diploid was sporulated on
minimal sporulation plates and tetrads were dissected onto
minimal medium plates without methionine. Despite low overall
spore viability, we obtained spores that carried the plasmid and
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Figure 2 GPI10 is essential for growth and its deletion can be
complemented by pGal-GPI10 or by p425-PIG-B
(A) The GPI10 open reading frame was replaced by KanMX in the diploid Cen.PK2 and tetrads
were dissected. (B) pGal-GPI10 was transformed into RH3699 and tetrads were dissected.
Growth on medium containing geneticin was used to monitor the deletion of GPI10. (C) p425-
PIG-B was transformed into RH3699 and tetrads were dissected onto minimal medium. The
growth of two spores (A, B, C and D) is shown : spore A was disrupted for GPI10, as monitored
by growth on medium containing geneticin, whereas the wild-type spore, B, cannot grow on
geneticin-containing plates.
which were resistant to geneticin (Figure 2C), suggesting that
theywere deleted for GPI10. PIG-B expression did not completely
restore wild-type growth levels in gpi10D : :KanMX strains [com-
pare spore A (gpi10D : :KanMX) and spore B (wild type) in
Figure 2C], but partial restoration of phenotypes is commonly
seen for functional complementation over such a large evol-
utionary distance. Expression of PIG-B from a centromeric
vector was not sufficient to restore growth (results not shown).
We conclude that expression of the human PIG-B cDNA can
complement the lethal phenotype of gpi10D : :KanMX cells,
suggesting that the two proteins are functional homologues.
Gpi10p depletion results in a GPI-synthesis defect
The GAL1}10-controlled GPI10 vector allowed us to regulate
the expression of GPI10. To find conditions where Gpi10p was
functionally depleted, we followed the growth of the spores of a
tetrad (Figure 2B) upon shift from glycerol- to glucose-containing
medium. As shown in Figure 3(A), the growth of
gpi10D : :KanMX cells slowed down significantly after about 8 h
incubation in glucose-containing medium, suggesting that
Gpi10p was strongly depleted. For the following experiments, we
used conditions where GPI10 expression was turned off for
8–16 h. We had also tried to shift cells from galactose- to glucose-
containing medium, but observed no change in growth rate over
Figure 3 Gpi10p depletion causes a GPI-anchoring defect
(A) The growth of the spores of one tetrad [RH3994 (A), RH3995 (B), RH3996 (C), RH3997
(D)] was monitored upon shift from glycerol- to glucose-containing medium. (B) Incorporation
of [3H]myo-inositol into proteins is shown for the spores of the tetrad. Cells were shifted from
glycerol- to glucose-containing medium for 16 h. They were then labelled with [3H]myo-inositol,
followed by preparation of a total cell lysate, analysis by SDS/PAGE and fluorography. (C)
Pulse–chase experiments were performed in the spores of the tetrad. Cells were shifted from
glycerol- to glucose-containing medium for 16 h. They were then metabolically labelled and
chased as indicated. Lysates were prepared which were immunoprecipitated for Gas1p. The
signal was detected by exposure and quantification of SDS gels using a PhosphorImager.
Quantification of these pulse–chase experiments are shown. The appearance of mature Gas1p
indicates GPI-anchor attachment and transport to the Golgi apparatus.
a period of 24 h (results not shown). This could be due to a very
high expression of Gpi1p on galactose medium combined with a
long half-life of the protein.
Since GPI10 appears to be the functional homologue of PIG-
B, we tested whether GPI10 is indeed involved in GPI-anchor
synthesis. GPI-anchored proteins are the only proteins that
incorporate [$H]myo-inositol due to the inositol residue in the
GPI anchor. Cells were grown in SGYE to saturation and used
to inoculate SDYE (5% glucose). After 16 h growth in SDYE
(5% glucose) the cells were labelled for 30 min with [$H]myo-
inositol, total protein was extracted and analysed by SDS}PAGE,
followed by fluorography. We observed that in gpi10D : :KanMX
spores (B and D), the incorporation of radiolabelled inositol was
greatly reduced when compared with the wild-type spores (A and
C), demonstrating a defect in GPI-anchoring (Figure 3B).
Furthermore, pulse–chase analysis of the GPI-anchored protein
Gas1p was performed. Gas1p occurs as a 105 kDa form in the
ER. Upon arrival at the Golgi, its core glycans are elongated,
causing a shift in apparent molecular mass from 105 to 125 kDa.
Transport of Gas1p from the ER to the Golgi depends on
addition of the GPI anchor [30,31]. After 16 h of shift from
SGYE medium to SDYE medium (5% glucose), cells were
labelled for 5 min and chased for various amounts of time. Cells
were lysed and either Gas1p or the non-GPI-anchored vacuolar
hydrolase carboxypeptidase Y was precipitated from total lysates
using polyclonal antisera. Immune complexes were separated by
SDS}PAGE and analysed on a PhosphorImager. As shown in
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Figure 4 Gpi10p depletion causes the accumulation of Man2-GlcN-(acyl)PI
and of a novel lipid
pmi40 (RH3998) or pmi40 gpi10D : : KanMX (RH3999), both carrying pGal-GPI10, were shifted
to glucose-containing medium for 16 h. Cells were labelled for 45 min with [14C]mannose,
followed by extraction of total lipids and analysis by TLC. Man2, Man2-GlcN-(acyl)PI ; MIPC,
mannosylinositolphosphorylceramide ; M(IP)2C, mannosyldi-inositolphosphorylceramide ; arrow,
novel lipid ; CP, complete precursor ; O, origin.
Figure 3(C), Gas1p maturation was severely delayed in
gpi10D : :KanMX spores (B and D) when compared with wild-
type spores (A and C). Under these conditions, maturation of
carboxypeptidase Y was normal in all four spores, showing that
its transport to the vacuole was unaffected (results not shown).
Therefore, the defect in maturation does not represent a general
transport defect. These data are consistent with a role for Gpi10p
in GPI-anchor synthesis.
Pig-B mutant cells are defective for the addition of the third
mannose to the intermediate structure Man-(EthN-P)Man-
GlcN-PI [32]. To test if GPI10 also mediates the addition of the
third mannose to the GPI intermediate, we performed lipid
labelling experiments in io. Wild-type yeast cells incorporate
little exogenously added mannose. We therefore used cells
carrying the pmi40 mutation, which is a temperature-sensitive
Table 2 Analysis of the lipid intermediates accumulated upon depletion of Gpi10p
RH3999 cells were metabolically labelled with [14C]Man, and total lipids were extracted and analysed by TLC. The bands corresponding to Man2-GlcN-(acyl)PI, the novel lipid (Figure 4, arrow)
and of lipid C [EthN-P-Man3-GlcN-(acyl)PI] from Trypanosoma brucei were eluted from the TLC material by organic solvents. Hydrophilic fragments were generated by nitrous acid deamination
and reduction, wherease neutral core glycans were generated by dephosphorylation, deamination and reduction. Hydrophilic fragments and neutral core glycans were analysed by Bio-Gel P4 size-
exclusion and Dionex high-pH anion-exchange chromatography (HPAEC) respectively. Partially hydrolysed glucose oligomers were used as internal standards. The elution position of the hydrophilic
fragments and the neutral core glycans are indicated as glucose units (GU) and Dionex units (DU) respectively. JBAM, Jack bean a-mannosidase.
Bio-Gel P4 Gel filtration analysis of the hydrophilic fragments Dionex HPAEC analysis of the neutral core glycans
Lipid (GU) (DU)
EthN-P-Man3-GlcN-(acyl)PI 7.8 2.5
Man2-GlcN-(acyl)PI 3.3 2.1
Novel lipid 7.3 2.1
Novel lipid (JBAM) 7.0/0.9 1.1
allele of phosphomannose isomerase. Upon shift to non-per-
missive temperature, these cells incorporate exogenously added
mannose with high efficiency. The pmi40 mutation was intro-
duced into a gpi10D : :KanMX strain containing pGal-GPI10
(RH3999). A pmi40 GPI10 strain derived from the same cross
was used as control (RH3998). Cells were grown to saturation in
YPG and shifted to SDCU medium (5% glucose) for 16 h. Cells
were preincubated for 10 min in the presence or absence of the
GPI-synthesis inhibitor, YW3548, which causes the accumulation
of Man
#
-GlcN-(acyl)PI [24]. After labelling for 45 min with
["%C]mannose, total lipids were extracted and analysed by TLC
(Figure 4). In wild-type cells, one can see some labelling of the
complete GPI precursor and mannosylated sphingolipids. When
the inhibitor YW3548 was added, a strong accumulation of a
band comigrating with Man
#
-GlcN-(acyl)PI occurred [24]. In
Gpi10p-depleted cells, Man
#
-GlcN-(acyl)PI accumulated even in
the absence of YW3548. In addition, a more polar lipid (indicated
with an arrow in Figure 4) was strongly labelled, which was
sensitive to treatment with GPI phospholipase D, but resistant to
digestion with PI phospholipase C, suggesting that the lipid had
an acylated inositol ring (results not shown). The appearance of
this lipid is strongly diminished by YW3548. From the novel
lipid and from the Man
#
-GlcN-(acyl)PI, hydrophilic fragments
were prepared by nitrous acid deamination and borohydride
reduction and were analysed by Bio-Gel P4 chromatography.
Furthermore, neutral glycans were prepared by treatment with
HF, followed by nitrous acid deamination and borohydride
reduction, and were analysed by Dionex chromatography (Table
2). In addition, the deaminated, reduced fragment derived from
the novel lipid was subjected to treatment with Jack bean
mannosidase followed by analysis by Dionex chromatography
(Table 2). The novel lipid is sensitive to treatment with HF,
contains the core glycan Man
#
-anhydromannitol and elutes from
a Bio-Gel P4 sizing column at 7.3 glucose units (GU). On the
same column, a deaminated, reduced fragment derived from T.
brucei lipid C (EthN-P-Man
$
-GlcN-PI) eluted at 7.8 GU. Jack
bean mannosidase treatment resulted in a shift in the elution
profile from 7.3 to 7.0 GU and the release of a fragment eluting
at 0.9 GU (mannose). These findings are consistent with a
structure Man-(EthN-P)Man-GlcN-(acyl)-PI. One additional
ethanolamine phosphate leads to an apparent size increase of
about 4 GU as previously demonstrated by comparing the elution
position of EthN-P-Man
$
-GlcN-PI and Man
$
-GlcN-PI [28].
GPI10 overexpression results in partial resistance to YW3548
As YW3548 prevents the addition of the third mannose to the
GPI intermediate Man
#
-GlcN-(acyl)PI and our data suggest that
158 C. Su$ tterlin and others
Figure 5 GPI10 overexpression confers partial resistance to the GPI-
synthesis inhibitor YW3548
(A) RH1657 cells carrying pGal or pGal-GPI10 were grown in YGal and incubated with 2 lg/ml
YW3548 or methanol and growth was monitored by counting cells in a haemocytometer. (B)
RH1657 cells carrying pGal or pGal-GPI10 were included in YGal plates and 4 ll of different
concentrations of YW3548 were spotted on the plates (top, 100 lg/ml ; middle, 10 lg/ml ; and
bottom, 1 lg/ml) before incubation at 30 °C.
GPI10 is required for this step, we decided to test whether
overexpression of GPI10 would lead to resistance to YW3548.
To address this question, we transformed wild-type cells with
either pGal-GPI10 or the empty pGal control vector. The growth
of cells in YGal medium in the presence of YW3548 or methanol
as control was monitored (Figure 5A). We observed that cells
carrying the control vector were unable to grow in the presence
of YW3548, whereas cells that expressed GPI10 from the
GAL1}10 promoter were able to overcome the effects of the
compound and grow, albeit more slowly, than untreated cells. In
a different assay, cells carrying either pGal-GPI10 or pGal were
included in YGal plates and halo assays were performed (Figure
5B). Cells carrying the control vector gave a completely clear
halo upon addition of YW3548. In contrast, overexpression of
GPI10 allowed partial growth in the presence of the compound.
Whereas the halo was clear in the beginning, it became turbid
after 2 days of incubation. This partial resistance suggests that
YW3548 might interfere directly or indirectly with the function
of Gpi10p.
DISCUSSION
In this study, we present the characterization of the GPI10 gene
from yeast. A deletion of the essential GPI10 gene can be
complemented by expression of the human PIG-B cDNA,
suggesting that GPI10 and PIG-B are functional homologues.
Both genes appear to mediate the same step in GPI-anchor
synthesis. Previous studies have indicated a high degree of
homology between the mammalian and the yeast GPI-anchor
synthesis machinery. The gpi8 ts mutant was shown to be
complemented by its human homologue [21]. Also, mammalian
class E mutants that are defective in Dol-P-Man synthase can be
complemented by the homologous yeast gene [33]. In this study
we show that a complete deletion of GPI10 can be complemented
by its human homologue, the PIG-B gene.
As expected from the sequence homology and the functional
complementation test, GPI10 is involved in GPI-anchor syn-
thesis. When GPI10 expression was repressed, radiolabelled
inositol incorporation into proteins was greatly reduced and
Gas1p maturation was strongly delayed, which is consistent with
a GPI-synthesis defect. All other genes that have been implicated
in yeast GPI-anchor synthesis have also been found to be
essential [18–22,34].
When GPI10 expression was turned off, Man
#
-GlcN-(acyl)PI
as well as a novel lipid were found to accumulate. This
lipid contained a Man
#
-anhydromannitol core glycan after
dephosphorylation, nitrous acid treatment and reduction. Its
hydrophilic fragment, however, eluted from a Bio-Gel P4 column
at a much later position, which could be due to an ethanolamine
phosphate attached to Man
#
-anhydromannitol. Furthermore, it
is sensitive to treatment with Jack bean mannosidase. These
findings suggest that the novel lipid may represent a GPI
intermediate, most likely Man-(EthN-P)Man-GlcN-(acyl)PI. For
the moment there is no formal proof that the aqueous HF-
sensitive group on the mannose is ethanolamine phosphate. At
this point different possibilities exist : it could represent an
aberrant structure, which is only synthesized due to extensive
pressure on the GPI-synthesis machinery imposed by the de-
pletion of Gpi10p, or it could represent a natural intermediate.
Most GPI anchors isolated from mature yeast proteins do not
seem to carry an ethanolamine phosphate modification on the
first mannose [35]. However, in animal cells, GPI molecules have
been identified with this modification [1], and the mammalian
PIG-B enzyme most likely acts on a GPI precursor with the same
carbohydrate structure that accumulated in this study. Previous
studies, which characterized the complete, radiolabelled GPI
precursor in yeast before it was added to the protein, would not
necessarily have detected this modification with the techniques
used [27].
Previously, we suggested that YW3548 blocked the addition of
the third mannose to the GPI core because when cells or
membranes were treated with the compound, a Man
#
-GPI
intermediate with two mannoses and no ethanolamine accumu-
lated. Here we have observed that the addition of a putative
ethanolamine phosphate to the Man
#
-GPI intermediate was
prevented by incubation of cells with YW3548. This raises the
possibility that the inhibition of the addition of the third mannose
to the GPI core is indirect and is due to the inhibition of
ethanolamine phosphate addition to the first mannose by
YW3548. Man-(EthN-P)Man-Glc-(acyl)PI could be the natural
and highly preferred substrate for Gpi10p, the putative a1,2
mannosyltransferase that adds the third mannose. In this case,
the biosynthetic scheme in yeast would be PI!GlcNAc-PI!
GlcN-PI! GlcN-(acyl)PI!Man-GlcN-(acyl)PI!Man-Man-
GlcN-(acyl)PI!Man-(EthN-P)Man-GlcN-(acyl)PI!Man-
Man-(EthN-P)Man-GlcN-(acyl)PI! (Man)Man-Man-(EthN-
P)Man-GlcN-(acyl)PI ! EthN-P-(Man)Man-Man-(EthN-
P)Man-GlcN-(acyl)PI and YW3548 would block the addition of
ethanolamine phosphate to the Man
#
intermediate. Consistent
with this synthetic scheme we have preliminary data on the
structure of a GPI product that accumulates in a mutant that is
defective in addition of the mannose side-chain. This product
159GP110, yeast homologue of human PIG-B
also appears to have an EthN-P on the first mannose of the core
GPI structure (C. Su$ tterlin, P. Gerold, R. Schwarz and H.
Riezman, unpublished work). This newly proposed sequence of
events in the yeast GPI synthesis pathway would also be
consistent with the lack of activity of YW3548 on all protozoa
tested [24], because these cells do not use this modification on the
first mannose [1]. Previously, we suggested that YW3548 might
mimic the Man
#
-GlcN-(acyl)PI substrate and compete for bind-
ing of this substrate to the a-1,2 mannosyltransferase [24]. This
same argument would hold for the phosphoethanolamine trans-
ferase needed to generate this novel yeast lipid.
Overexpression of GPI10 can confer partial resistance to
YW3548, as tested by growth in the presence of YW3548. The
partial resistance could be explained if Gpi10p were one of the
targets of YW3548 or if the real target is the phospho-
ethanolamine transferase that works on the first mannose. In the
latter case, Gpi10p may utilize the unmodified Man
#
-GPI only
poorly as a substrate. Although no mannosyltransferase activity
of Gpi10p and the Pig-B protein have been shown, both proteins
share significant homology with Alg9p (18% identity, 31%
similarity). Alg9p is involved in the transfer of the seventh
mannose in N-glycan precursor synthesis [36]. The mannose in
that case is also donated by Dol-P-Man and is attached in an a-
1,2 linkage. It is therefore likely that Pig-B, Gpi10p and Alg9p
represent a new family of Dol-P-Man-requiring a-1,2 mannosyl-
transferases.
The identification of GPI10 as a gene involved in an in-
termediate step of GPI-anchor synthesis improves the charac-
terization of the yeast GPI-synthesis machinery. Functional
complementation could also allow the cloning of the protozoan
enzymes which, at least in their native environments, have been
shown not to be sensitive to YW3548 [24]. Expression of these
genes in yeast may make it possible to screen for compounds that
specifically interfere with the addition of the third mannose
residue in fungi or protozoa.
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